Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Vaccine Effectiveness × Gynecologic × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Ovarian Neoplasms 1756 Uterine Cervical Neoplasms 1473 Endometrial Neoplasms 819 Breast Neoplasms 427 Carcinoma, Ovarian Epithelial 404 Fallopian Tube Neoplasms 397 Uterine Cervical Dysplasia 272 Neoplasms 251 Colorectal Neoplasms 177 Uterine Neoplasms 172 Peritoneal Neoplasms 169 Vulvar Neoplasms 154 Lung Neoplasms 148 Pancreatic Neoplasms 139 Prostatic Neoplasms 134 Stomach Neoplasms 126 Recurrence 125 Colonic Neoplasms 114 Papillomavirus Infections 112 Melanoma 100 Sarcoma 96 Urinary Bladder Neoplasms 95 Vaginal Neoplasms 92 Head and Neck Neoplasms 90 Carcinoma, Non-Small-Cell Lung 89 Neoplasm Metastasis 82 Esophageal Neoplasms 82 Testicular Neoplasms 80 Rectal Neoplasms 71 Kidney Neoplasms 62

Interventions

Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07256912 2026-03-24

CervALONE

International Agency for Research on Cancer

Phase 4 Not yet recruiting

Vaccine Effectiveness

Data powered by HemOnc (CC BY 4.0) Colophon ⚡